Dopaminergic network differences in human impulsivity. Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Shelby ES, Smith CE, Kessler RM, Zald DH (2010) Science 329: 532 Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Ramamoorthy S, Blakely RD (1999) Science 285: 763-6 Sex differences in amphetamine-induced displacement of [(18)F]fallypride in striatal and extrastriatal regions: a PET study. Riccardi P, Zald D, Li R, Park S, Ansari MS, Dawant B, Anderson S, Woodward N, Schmidt D, Baldwin R, Kessler R (2006) Am J Psychiatry 163: 1639-41 Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder. Hart AB, Gamazon ER, Engelhardt BE, Sklar P, Kähler AK, Hultman CM, Sullivan PF, Neale BM, Faraone SV, Psychiatric Genomics Consortium: ADHD Subgroup, de Wit H, Cox NJ, Palmer AA (2014) Proc Natl Acad Sci U S A 111: 5968-73 A thalamocorticostriatal dopamine network for psychostimulant-enhanced human cognitive flexibility. Samanez-Larkin GR, Buckholtz JW, Cowan RL, Woodward ND, Li R, Ansari MS, Arrington CM, Baldwin RM, Smith CE, Treadway MT, Kessler RM, Zald DH (2013) Biol Psychiatry 74: 99-105 Amping up effort: effects of d-amphetamine on human effort-based decision-making. Wardle MC, Treadway MT, Mayo LM, Zald DH, de Wit H (2011) J Neurosci 31: 16597-602 Similar potency ratios of amphetamine optical isomers for inhibition of dopamine uptake by synaptosomes of corpus striatum, olfactory tubercle and prefrontal cortex of the rat. Matthews RT, Shore PA (1984) Biochem Pharmacol 33: 2817-9 Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. Barker EL, Kimmel HL, Blakely RD (1994) Mol Pharmacol 46: 799-807 Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine. Smith CT, Dang LC, Cowan RL, Kessler RM, Zald DH (2016) Neuropharmacology 108: 394-402 Lack of consistent sex differences in D-amphetamine-induced dopamine release measured with [F]fallypride PET. Smith CT, Dang LC, Burgess LL, Perkins SF, San Juan MD, Smith DK, Cowan RL, Le NT, Kessler RM, Samanez-Larkin GR, Zald DH (2019) Psychopharmacology (Berl) 236: 581-590 Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology. Smith CT, Weafer J, Cowan RL, Kessler RM, Palmer AA, de Wit H, Zald DH (2016) J Psychopharmacol 30: 330-43 Potentiation of apomorphine and D-amphetamine effects by naloxone. Adams PM, Beauchamp R, Alston C (1981) Life Sci 28: 629-34 Traumatic brain injury-related attention deficits: treatment outcomes with lisdexamfetamine dimesylate (Vyvanse). Tramontana MG, Cowan RL, Zald D, Prokop JW, Guillamondegui O (2014) Brain Inj 28: 1461-72
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.